Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AMRXAmneal Pharmaceuticals, Inc.

Nasdaq · CIK 0001723128
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts468

Identity from submissions API

NameAmneal Pharmaceuticals, Inc.
CIK0001723128
TickersAMRX
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporation—
Phone(908) 947-3120
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Atlas Holdings, Inc. (2017-11-21T05:00:00.000Z → 2018-04-13T04:00:00.000Z)
Business address
—
Mailing address
400 CROSSING BOULEVARD
3RD FLOOR
BRIDGEWATER
NJ
08807
NJ

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

695 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-09 10-Q 10-Q 0001723128-26-000040 001-38485 261536281 34 14741877 1 1
2026-11-03 8-K 8-K 2.02,7.01,9.01 0001723128-26-000035 001-38485 261514254 34 911470 1 1
2026-10-23 8-K/A 8-K/A 9.01 0001140361-26-040656 001-38485 261482218 34 3166049 1 1
2026-09-21 4 FORM 4 0001628280-26-062915 5685
2026-09-14 4 FORM 4 0001628280-26-061836 7342
2026-09-03 S-3ASR S-3ASR 0001140361-26-035617 333-298741 261358995 33 587305 1 1
2026-09-02 4 FORM 4 0001628280-26-060179 4845
2026-08-25 4 FORM 4 0001628280-26-058918 4846
2026-08-14 4 FORM 4 0001628280-26-057147 6628
2026-08-13 4 FORM 4 0001628280-26-056757 5188
2026-08-13 4 FORM 4 0001628280-26-056754 7061
2026-08-13 4 FORM 4 0001628280-26-056752 5770
2026-08-13 144 xsl144X01/primary_doc.xml 0001628280-26-056733 001-38485 261273579 33 5128
2026-08-12 4 FORM 4 0000898432-26-000655 5636
2026-08-12 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000898432-26-000654 005-90473 261269117 34 9801
2026-08-12 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000898432-26-000653 005-90473 261269106 34 10338
2026-08-12 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000898432-26-000652 005-90473 261269100 34 10477
2026-08-12 4 FORM 4 0001628280-26-056297 6970
2026-08-12 4 FORM 4 0001628280-26-056288 6207
2026-08-12 4 FORM 4 0001628280-26-056285 6993
2026-08-12 144 xsl144X01/primary_doc.xml 0001628280-26-056220 001-38485 261267776 33 5769
2026-08-12 144 xsl144X01/primary_doc.xml 0001628280-26-056196 001-38485 261267589 33 4510
2026-08-11 144 xsl144X01/primary_doc.xml 0001949846-26-000494 001-38485 261261820 33 6941
2026-08-10 8-K 8-K 1.01,2.01,2.03,3.02,7.01,9.01 0001140361-26-032014 001-38485 261258369 34 369864 1 1
2026-08-06 10-Q 10-Q 0001723128-26-000031 001-38485 261250463 34 11462302 1 1
2026-08-03 8-K 8-K 1.01 0001628280-26-051900 001-38485 261233366 34 79945719 1 1
2026-07-31 8-K 8-K 5.07 0001140361-26-030491 001-38485 261228614 34 168445 1 1
2026-07-30 DEFA14A DEFA14A 0001140361-26-030141 001-38485 261220034 34 862162
2026-07-30 8-K 8-K 2.02,7.01,9.01 0001723128-26-000025 001-38485 261220002 34 832920 1 1
2026-06-29 DEFM14A DEFM14A 0001140361-26-026611 001-38485 261131138 34 7571610
2026-06-18 PREM14A PREM14A 0001140361-26-025784 001-38485 261103839 34 7686600 1 1
2026-05-12 4 FORM 4 0001628280-26-034106 5143
2026-05-11 144 xsl144X01/primary_doc.xml 0001628280-26-033749 001-38485 26965007 33 4663
2026-05-08 4 FORM 4 0001628280-26-032929 9847
2026-05-08 4 FORM 4 0001628280-26-032925 9220
2026-05-08 4 FORM 4 0001628280-26-032924 9217
2026-05-08 4 FORM 4 0001628280-26-032922 9201
2026-05-08 4 FORM 4 0001628280-26-032911 9179
2026-05-08 4 FORM 4 0001628280-26-032910 9143
2026-05-08 4 FORM 4 0001628280-26-032907 9331
2026-05-08 4 FORM 4 0001628280-26-032904 9179
2026-05-07 10-Q 10-Q 0001723128-26-000020 001-38485 26953856 34 9155796 1 1
2026-05-07 8-K 8-K 5.07 0001628280-26-032137 001-38485 26953548 34 198659 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001723128-26-000019 001-38485 26953252 34 586734 1 1
2026-04-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001669 005-90473 26901117 34 11006
2026-04-23 DEFA14A DEFA14A 0001193125-26-173760 001-38485 26888918 34 189955
2026-04-22 DEFA14A DEFA14A 0001193125-26-170732 001-38485 26884570 34 2729504
2026-04-22 DEFA14A DEFA14A 0001193125-26-170540 001-38485 26884160 34 40636
2026-04-22 DEFA14A DEFA14A 0001193125-26-170531 001-38485 26884143 34 815437
2026-04-22 DEFA14A DEFA14A 0001193125-26-170525 001-38485 26884129 34 27804
2026-04-22 DEFA14A DEFA14A 0001193125-26-170519 001-38485 26884119 34 12673588
2026-04-22 DEFA14A DEFA14A 0001193125-26-168237 001-38485 26881240 34 1145709
2026-04-22 8-K 8-K 1.01,2.02,3.02,7.01,9.01 0001193125-26-168231 001-38485 26881238 34 1516738 1 1
2026-03-27 4/A FORM 4/A 0001628280-26-021746 6707
2026-03-27 4/A FORM 4/A 0001628280-26-021742 6729
2026-03-26 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000898432-26-000204 005-90473 26800120 34 6796
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000639 005-90473 26797726 34 7153
2026-03-25 DEFA14A DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS 0001308179-26-000144 001-38485 26792644 34 5725476
2026-03-25 DEF 14A DEFINITIVE PROXY STATEMENT 0001308179-26-000143 001-38485 26792633 34 25651374 1 1
2026-03-05 4 FORM 4 0001628280-26-015285 20629
2026-03-05 4 FORM 4 0001628280-26-015283 20655
2026-03-05 4 FORM 4 0001628280-26-015241 30003
2026-03-05 4 FORM 4 0001628280-26-015239 30000
2026-03-05 4 FORM 4 0001628280-26-015238 30004
2026-03-05 4 FORM 4 0001628280-26-015235 30023
2026-03-03 4 FORM 4 0001628280-26-013900 8379
2026-03-03 4 FORM 4 0001628280-26-013893 8401
2026-03-03 4 FORM 4 0001628280-26-013890 8379
2026-03-03 4 FORM 4 0001628280-26-013887 8355
2026-03-03 4 FORM 4 0001628280-26-013882 8366
2026-03-03 4 FORM 4 0001628280-26-013878 8360
2026-02-27 10-K 10-K 0001723128-26-000011 001-38485 26700249 34 19885473 1 1
2026-02-27 8-K 8-K 2.02,7.01,9.01 0001723128-26-000008 001-38485 26692376 34 695813 1 1
2026-02-03 8-K 8-K 1.01,2.03 0001628280-26-004738 001-38485 26589380 34 2337931 1 1
2026-01-28 8-K 8-K 8.01 0001628280-26-003842 001-38485 26572643 34 137940 1 1
2026-01-13 8-K 8-K 2.02,7.01 0001723128-26-000003 001-38485 26528427 34 157068 1 1
2025-11-19 4 FORM 4 0001628280-25-053188 4934
2025-11-17 144 xsl144X01/primary_doc.xml 0001949846-25-000603 001-38485 251490768 33 4184
2025-11-14 4 FORM 4 0001628280-25-052413 11893
2025-11-12 144 xsl144X01/primary_doc.xml 0001628280-25-051697 001-38485 251474192 33 8776
2025-11-06 10-Q 10-Q 0001723128-25-000062 001-38485 251458526 34 11216018 1 1
2025-10-30 8-K 8-K 2.02,7.01,9.01 0001723128-25-000059 001-38485 251432038 34 722745 1 1
2025-10-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000898432-25-000809 005-90473 251381048 34 277040
2025-10-06 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000898432-25-000785 005-90473 251376658 34 1320394
2025-08-28 4 FORM 4 0001781149-25-000006 4967
2025-08-27 144 xsl144X01/primary_doc.xml 0002007317-25-000975 001-38485 251264318 33 4141
2025-08-25 4 FORM 4 0001738061-25-000004 6934
2025-08-22 4 FORM 4 0001628280-25-041033 8475
2025-08-22 144 xsl144X01/primary_doc.xml 0002007317-25-000949 001-38485 251246237 33 6470
2025-08-22 144 xsl144X01/primary_doc.xml 0001949846-25-000405 001-38485 251244609 33 5302
2025-08-20 144 xsl144X01/primary_doc.xml 0002007317-25-000917 001-38485 251236960 33 5322
2025-08-20 144 xsl144X01/primary_doc.xml 0001949846-25-000393 001-38485 251234546 33 6970
2025-08-15 4 FORM 4 0001723128-25-000052 5048
2025-08-15 4 FORM 4 0001723128-25-000051 8796
2025-08-15 144 xsl144X01/primary_doc.xml 0001949846-25-000378 001-38485 251223128 33 6354
2025-08-14 144 xsl144X01/primary_doc.xml 0002007317-25-000875 001-38485 251219061 33 6470
2025-08-13 4 FORM 4 0001723128-25-000050 5048
2025-08-13 4 FORM 4 0001723128-25-000049 5033
2025-08-13 4 FORM 4 0001723128-25-000048 5028
2025-08-13 144 xsl144X01/primary_doc.xml 0001949846-25-000368 001-38485 251210919 33 5741
2025-08-13 144 xsl144X01/primary_doc.xml 0001949846-25-000362 001-38485 251209520 33 4613
2025-08-12 144 xsl144X01/primary_doc.xml 0001949846-25-000361 001-38485 251206658 33 4724
2025-08-12 144 xsl144X01/primary_doc.xml 0002007317-25-000849 001-38485 251206568 33 4142
2025-08-12 144 xsl144X01/primary_doc.xml 0001949846-25-000360 001-38485 251206191 33 4735
2025-08-08 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000898432-25-000584 005-90473 251199920 34 355757
2025-08-07 10-Q 10-Q 0001723128-25-000047 001-38485 251194079 34 87042146 1 1
2025-08-05 8-K/A 8-K/A 5.07 0001723128-25-000040 001-38485 251185624 34 141579 1 1
2025-08-05 8-K 8-K 2.02,7.01,9.01 0001723128-25-000037 001-38485 251182649 34 705839 1 1
2025-08-01 8-K FORM 8-K 1.01,2.03,9.01 0000950103-25-009701 001-38485 251176534 34 5942509 1 1
2025-07-24 8-K FORM 8-K 8.01,9.01 0000950103-25-009253 001-38485 251147927 34 191192 1 1
2025-07-21 8-K FORM 8-K 8.01,9.01 0000950103-25-009025 001-38485 251135731 34 209259 1 1
2025-07-21 8-K 8-K 2.02,5.02,7.01,9.01 0001723128-25-000033 001-38485 251135729 34 307570 1 1
2025-06-18 4 FORM 4 0001628280-25-032108 5241
2025-06-12 4 FORM 4 0001628280-25-030958 4989
2025-05-19 4 FORM 4 0001628280-25-026513 5047
2025-05-16 144 xsl144X01/primary_doc.xml 0002007317-25-000405 001-38485 25958951 33 6397
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000898432-25-000342 005-90473 25946925 34 7319
2025-05-13 4 FORM 4 0001628280-25-025140 4966
2025-05-12 144 xsl144X01/primary_doc.xml 0002007317-25-000348 001-38485 25934798 33 4714
2025-05-08 4 FORM 4 0001628280-25-024004 9710
2025-05-08 4 FORM 4 0001628280-25-024000 9046
2025-05-08 4 FORM 4 0001628280-25-023998 9086
2025-05-08 4 FORM 4 0001628280-25-023993 9010
2025-05-08 4 FORM 4 0001628280-25-023991 9046
2025-05-08 4 FORM 4 0001628280-25-023989 9084
2025-05-08 4 FORM 4 0001628280-25-023987 9086
2025-05-08 4 FORM 4 0001628280-25-023985 9206
2025-05-08 4 FORM 4 0001628280-25-023966 9068
2025-05-08 8-K 8-K 5.07 0001723128-25-000024 001-38485 25926551 34 227599 1 1
2025-05-07 10-Q 10-Q 0001723128-25-000022 001-38485 25922103 34 8896507 1 1
2025-05-06 4 FORM 4 0001628280-25-022719 6647
2025-05-02 144 xsl144X01/primary_doc.xml 0001968582-25-000308 001-38485 25909303 33 6467
2025-05-02 8-K 8-K 2.02,7.01,9.01 0001723128-25-000018 001-38485 25905396 34 533005 1 1
2025-04-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000656 005-90473 25893591 34 6111
2025-04-02 4 FORM 4 0001628280-25-016184 5240
2025-03-25 DEFA14A DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS 0001308179-25-000221 001-38485 25768504 34 4790749
2025-03-25 DEF 14A DEFINITIVE PROXY STATEMENT 0001308179-25-000220 001-38485 25768491 34 16976517 1 1
2025-03-17 4 xslF345X05/form4.xml 0000898432-25-000191 4395
2025-03-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000898432-25-000189 005-90473 25745226 34 6635
2025-03-14 144 xsl144X01/primary_doc.xml 0001971522-25-000003 001-38485 25741923 33 4362
2025-03-12 4 FORM 4 0001628280-25-012344 5499
2025-03-07 4 FORM 4 0001628280-25-011310 5035
2025-03-07 4 FORM 4 0001628280-25-011306 6923
2025-03-07 4 FORM 4 0001628280-25-011303 5030
2025-03-07 4 FORM 4 0001628280-25-011300 5012
2025-03-06 8-K 8-K 5.02 0001723128-25-000014 001-38485 25715462 34 152651 1 1
2025-03-05 4 FORM 4 0001628280-25-010719 30138
2025-03-05 4 FORM 4 0001628280-25-010718 30133
2025-03-05 4 FORM 4 0001628280-25-010713 30133
2025-03-05 4 FORM 4 0001628280-25-010693 20756
2025-03-05 4 FORM 4 0001628280-25-010688 20738
2025-03-05 4 FORM 4 0001628280-25-010679 5249
2025-03-05 4 FORM 4 0001628280-25-010678 30133
2025-03-05 144 xsl144X01/primary_doc.xml 0002002698-25-000014 001-38485 25712235 33 6437
2025-03-05 144 xsl144X01/primary_doc.xml 0002002698-25-000012 001-38485 25712212 33 5864
2025-03-05 144 xsl144X01/primary_doc.xml 0002002698-25-000011 001-38485 25712134 33 5817
2025-03-05 144 xsl144X01/primary_doc.xml 0001949846-25-000100 001-38485 25709208 33 4667
2025-03-04 4 FORM 4 0001628280-25-010118 8838
2025-03-04 4 FORM 4 0001628280-25-010115 8833
2025-03-04 4 FORM 4 0001628280-25-010113 8855
2025-02-28 10-K 10-K 0001723128-25-000012 001-38485 25691583 34 22061447 1 1
2025-02-28 8-K 8-K 2.02,7.01,9.01 0001723128-25-000009 001-38485 25682368 34 732618 1 1
2025-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001610520-25-000006 005-90473 25603866 34 6454
2025-02-05 4 FORM 4 0001628280-25-004064 5247
2025-01-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000898432-25-000062 005-90473 25551131 34 6353
2025-01-15 8-K 8-K 2.02,7.01 0001723128-25-000005 001-38485 25531060 34 164562 1 1
2025-01-10 4 FORM 4 0001628280-25-001153 5250
2025-01-06 4 FORM 4 0001628280-25-000581 5249
2025-01-02 144 xsl144X01/primary_doc.xml 0001968582-25-000017 001-38485 25502674 33 4486
2024-11-26 4 FORM 4 0001628280-24-049297 8109
2024-11-25 4 FORM 4 0001628280-24-049149 6909
2024-11-22 4 FORM 4 0001628280-24-049005 4518
2024-11-22 144 xsl144X01/primary_doc.xml 0002002698-24-000462 001-38485 241487211 33 4143
2024-11-21 144 xsl144X01/primary_doc.xml 0002002698-24-000452 001-38485 241483503 33 4202
2024-11-19 4 FORM 4 0001628280-24-048437 5040
2024-11-15 144 xsl144X01/primary_doc.xml 0002007317-24-000631 001-38485 241467037 33 5214
2024-11-14 SC 13G/A SC 13G/A 0000898432-24-000923 005-90473 241462271 34 50393
2024-11-12 8-K/A 8-K/A 2.02,7.01,9.01 0001723128-24-000044 001-38485 241448715 34 704819 1 1
2024-11-12 10-Q 10-Q 0001723128-24-000042 001-38485 241448454 34 10961548 1 1
2024-11-08 8-K 8-K 2.02,7.01,9.01 0001723128-24-000037 001-38485 241437848 34 535564
2024-10-31 SC 13D/A SCHEDULE 13D/A 0000898432-24-000861 005-90473 241416552 34 1471198
2024-10-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001610520-24-000160 005-90473 241408153 34 7181
2024-10-01 8-K 8-K 7.01,9.01 0001628280-24-041646 001-38485 241341299 34 1002882 1 1
2024-08-16 4 FORM 4 0001628280-24-037559 6946
2024-08-16 4 FORM 4 0001628280-24-037557 5058
2024-08-14 144 xsl144X01/primary_doc.xml 0002002698-24-000190 001-38485 241207094 33 6953
2024-08-14 144 xsl144X01/primary_doc.xml 0002002698-24-000189 001-38485 241206805 33 8097
2024-08-14 144 xsl144X01/primary_doc.xml 0001949846-24-000460 001-38485 241205279 33 4155
2024-08-09 10-Q 10-Q 0001723128-24-000032 001-38485 241193188 34 10538151 1 1
2024-08-09 8-K 8-K 2.02,7.01,9.01 0001723128-24-000030 001-38485 241190319 34 748382 1 1
2024-05-20 4 FORM 4 0001628280-24-024342 7196
2024-05-16 144 xsl144X01/primary_doc.xml 0001971857-24-000236 001-38485 24955021 33 4177
2024-05-14 4 FORM 4 0001628280-24-023262 6805
2024-05-14 4 FORM 4 0001628280-24-023258 6805
2024-05-14 4 FORM 4 0001628280-24-023256 6928
2024-05-14 4 FORM 4 0001628280-24-023252 6764
2024-05-14 4 FORM 4 0001628280-24-023248 6802
2024-05-14 4 FORM 4 0001628280-24-023247 6736
2024-05-14 4 FORM 4 0001628280-24-023246 6728
2024-05-14 4 FORM 4 0001628280-24-023244 6749
2024-05-14 4 FORM 4 0001628280-24-023241 6786
2024-05-13 SC 13D/A SCHEDULE 13D/A 0000898432-24-000401 005-90473 24939251 34 188775
2024-05-08 10-Q 10-Q 0001723128-24-000021 001-38485 24927030 34 8724432 1 1
2024-05-07 8-K 8-K 5.07 0001628280-24-021107 001-38485 24922205 34 218816 1 1
2024-05-06 4 FORM 4 0001628280-24-020746 5510
2024-05-06 4 FORM 4 0001628280-24-020741 5546
2024-05-06 4 FORM 4 0001628280-24-020740 5489
2024-05-06 4 FORM 4 0001628280-24-020735 5525
2024-05-06 4 FORM 4 0001628280-24-020730 5563
2024-05-06 4 FORM 4 0001628280-24-020722 5496
2024-05-06 4 FORM 4 0001628280-24-020719 5566
2024-05-06 4 FORM 4 0001628280-24-020715 5565
2024-05-06 4 FORM 4 0001628280-24-020711 5685
2024-05-03 8-K 8-K 2.02,7.01,9.01 0001723128-24-000018 001-38485 24910686 34 508223 1 1
2024-04-24 SC 13G/A SC 13G/A 0001104659-24-050772 005-90473 24866610 34 58448
2024-03-22 DEFA14A AMNEAL PHARMACEUTICALS, INC. - DEFA14A 0001308179-24-000232 001-38485 24773136 34 933765
2024-03-22 DEF 14A AMNEAL PHARMACEUTICALS, INC. - DEF 14A 0001308179-24-000231 001-38485 24773134 34 7590460 1 1
2024-03-14 10-K 10-K 0001723128-24-000014 001-38485 24751168 34 19517797 1 1
2024-03-14 4 FORM 4 0001628280-24-011223 8834
2024-03-06 4 FORM 4 0001628280-24-009481 223184
2024-03-06 4 FORM 4 0001628280-24-009480 197352
2024-03-05 4 FORM 4 0001628280-24-008979 24006
2024-03-05 4 FORM 4 0001628280-24-008977 18963
2024-03-05 4 FORM 4 0001628280-24-008951 24015
2024-03-05 4 FORM 4 0001628280-24-008945 24027
2024-03-01 8-K 8-K 2.02,7.01,9.01 0001723128-24-000007 001-38485 24706754 34 754897 1 1
2024-02-29 4 FORM 4 0001628280-24-007998 8842
2024-02-29 4 FORM 4 0001628280-24-007994 8862
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020277 005-90473 24627374 34 13080
2024-01-10 8-K 8-K 2.02,7.01 0001723128-24-000003 001-38485 24524849 34 168516 1 1
2024-01-05 SC 13G SC 13G 0000898432-24-000029 005-90473 24516328 34 51505
2024-01-03 4 xslF345X05/form4.xml 0000898432-24-000011 6729
2024-01-03 SC 13D/A SCHEDULE 13D/A 0000898432-24-000009 005-90473 24507010 34 64962
2023-12-27 CERT 8A_Cert_AMRX.pdf 0001354457-23-000991 001-38485 231514351 34 133681
2023-12-26 25 25 0001193125-23-303015 001-38485 231513437 34 12611
2023-12-26 8-A12B 8-A12B 0001193125-23-303010 001-38485 231513362 34 14722
2023-12-15 8-K 8-K 3.01,7.01,9.01 0001193125-23-296658 001-38485 231490524 34 162095 1 1
2023-12-15 8-K/A 8-K/A 9.01 0001193125-23-296632 001-38485 231490330 34 297767 1 1
2023-12-12 SC 13G/A SC 13G/A 0001104659-23-125126 005-90473 231479877 34 58492
2023-12-01 SC 13D/A SCHEDULE 13D/A 0000898432-23-000828 005-90473 231459716 34 64207
2023-12-01 4/A FORM 4/A 0000898432-23-000827 5821
2023-11-20 15-12G 15-12G 0001193125-23-280165 001-38485 231420644 34 13285
2023-11-14 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-273644,2023-11-14 9999999995-23-003319 333-263226 231408930 33 1705
2023-11-14 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-273641,2023-11-14 9999999995-23-003318 333-263225 231408928 33 1705
2023-11-14 8-K 8-K 1.01,2.03,9.01 0001193125-23-277184 001-38485 231407785 34 5890195 1 1
2023-11-09 10-Q 10-Q 0001723128-23-000044 001-38485 231389578 34 225863015 1 1
2023-11-08 4 FORM 4 SUBMISSION 0001209191-23-054742 9126
2023-11-08 4 FORM 4 SUBMISSION 0001209191-23-054741 10108
2023-11-08 4 FORM 4 SUBMISSION 0001209191-23-054740 9107
2023-11-08 4 FORM 4 SUBMISSION 0001209191-23-054739 9764
2023-11-08 4 FORM 4 SUBMISSION 0001209191-23-054738 9742
2023-11-08 S-8 POS S-8 POS 0001193125-23-273651 333-224700 231389259 33 76001
2023-11-08 S-8 POS S-8 POS 0001193125-23-273646 333-248070 231389239 33 76001
2023-11-08 S-8 POS S-8 POS 0001193125-23-273645 333-273824 231389233 33 76001
2023-11-08 POS AM POS AM 0001193125-23-273644 333-263226 231389231 33 77251
2023-11-08 POS AM POS AM 0001193125-23-273641 333-263225 231389224 33 65454
2023-11-08 SC 13D/A SC 13D/A 0001193125-23-273628 005-90473 231389171 34 41395
2023-11-08 SC 13D/A SC 13D/A 0001193125-23-273625 005-90473 231389141 34 41097
2023-11-08 SC 13D/A SC 13D/A 0001193125-23-273619 005-90473 231389088 34 41411
2023-11-08 SC 13D/A SC 13D/A 0001193125-23-273614 005-90473 231389028 34 41457
2023-11-08 SC 13D/A SC 13D/A 0001193125-23-273607 005-90473 231388981 34 41368
2023-11-08 25-NSE xslF25X02/primary_doc.xml 0000876661-23-000826 001-38485 231386338 34 4323
2023-11-08 8-K12B 8-K12B 1.01,3.01,3.02,3.03,5.01,5.02,5.03,8.01,9.01 0001193125-23-272933 001-38485 231385991 34 1756102 1 1
2023-11-07 8-K 8-K 2.02,7.01,9.01 0001723128-23-000038 001-38485 231381420 34 739890 1 1
2023-10-23 8-K 8-K 2.02,7.01,9.01 0001723128-23-000035 001-38485 231340167 34 333915 1 1
2023-10-18 SC 13D/A SC 13D/A 0001193125-23-257893 005-90473 231330655 34 72527
2023-10-18 SC 13D/A SC 13D/A 0001193125-23-257891 005-90473 231330654 34 73112
2023-10-18 SC 13D/A SC 13D/A 0001193125-23-257890 005-90473 231330653 34 71901
2023-10-18 SC 13D/A SC 13D/A 0001193125-23-257885 005-90473 231330648 34 72907
2023-10-18 SC 13D/A SC 13D/A 0001193125-23-257880 005-90473 231330647 34 75158
2023-10-17 8-K 8-K 1.01,7.01,9.01 0001193125-23-257254 001-38485 231328432 34 195124 1 1
2023-08-15 4 FORM 4 SUBMISSION 0001209191-23-045846 5111
2023-08-11 144/A xsl144X01/primary_doc.xml 0001949846-23-000271 001-38485 231164768 33 4775
2023-08-11 144 xsl144X01/primary_doc.xml 0001971857-23-000517 001-38485 231163657 33 4110
2023-08-11 144 xsl144X01/primary_doc.xml 0001949846-23-000269 001-38485 231162526 33 5232
2023-08-09 S-8 S-8 0001193125-23-206845 333-273824 231153510 33 65891
2023-08-08 10-Q 10-Q 0001723128-23-000031 001-38485 231152263 34 11362840 1 1
2023-08-04 8-K 8-K 2.02,7.01,9.01 0001723128-23-000027 001-38485 231142065 34 734144 1 1
2023-08-01 4 FORM 4 SUBMISSION 0001209191-23-043988 7047
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-041087 9292
2023-05-19 8-K 8-K 8.01,9.01 0001193125-23-149302 001-38485 23940072 34 229962 1 1
2023-05-12 8-K 8-K 5.07 0001723128-23-000023 001-38485 23916266 34 241261 1 1
2023-05-11 4 FORM 4 SUBMISSION 0001209191-23-028730 11365
2023-05-11 4 FORM 4 SUBMISSION 0001209191-23-028737 11249
2023-05-11 4 FORM 4 SUBMISSION 0001209191-23-028736 7350
2023-05-11 4 FORM 4 SUBMISSION 0001209191-23-028735 11191
2023-05-11 4 FORM 4 SUBMISSION 0001209191-23-028732 11180
2023-05-11 4 FORM 4 SUBMISSION 0001209191-23-028734 11170
2023-05-11 4 FORM 4 SUBMISSION 0001209191-23-028733 12303
2023-05-11 4 FORM 4 SUBMISSION 0001209191-23-028729 11244
2023-05-11 4 FORM 4 SUBMISSION 0001209191-23-028731 11163
2023-05-09 10-Q 10-Q 0001723128-23-000020 001-38485 23903025 34 10416443 1 1
2023-05-05 8-K 8-K 2.02,7.01,9.01 0001723128-23-000017 001-38485 23891109 34 532670 1 1
2023-04-17 8-K 8-K 2.02,7.01,9.01 0001723128-23-000012 001-38485 23822773 34 245118 1 1
2023-03-24 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-060232,2023-03-24 9999999995-23-000655 333-263225 23761335 33 1704
2023-03-24 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-060233,2023-03-24 9999999995-23-000656 333-263226 23761330 33 1704
2023-03-24 DEFA14A AMNEAL PHARMACEUTICALS, INC. - DEFA14A 0001308179-23-000352 001-38485 23757701 34 209289
2023-03-24 DEF 14A AMNEAL PHARMACEUTICALS, INC. - DEF 14A 0001308179-23-000351 001-38485 23757696 34 7755936 1 1
2023-03-14 4 FORM 4 SUBMISSION 0001209191-23-018472 7322
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016934 14757
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016933 12852
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016932 6208
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016930 6230
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016929 14738
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016935 16247
2023-03-06 POS AM POS AM 0001193125-23-060233 333-263226 23706288 33 335372
2023-03-06 POS AM POS AM 0001193125-23-060232 333-263225 23706272 33 302024
2023-03-03 10-K 10-K 0001723128-23-000009 001-38485 23705565 34 22462545 1 1
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015521 14739
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015519 14758
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015516 8851
2023-03-02 POSASR POSASR 0001193125-23-058305 333-263226 23700127 33 359545
2023-03-02 POSASR POSASR 0001193125-23-058266 333-263225 23699802 33 334016
2023-03-02 8-K 8-K 2.02,7.01,9.01 0001723128-23-000006 001-38485 23696249 34 803510 1 1
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014118 10736
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014120 10741
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015299 005-90473 23602378 34 12973
2023-01-10 8-K 8-K 2.02,7.01 0001193125-23-005141 001-38485 23519616 34 151678 1 1
2022-12-14 SC 13D/A AMENDMENT TO FORM SC 13D 0001387131-22-012413 005-90473 221462864 34 75654
2022-12-14 4 CHANGES IN BENEFICIAL OWNERSHIP 0001387131-22-012411 13314
2022-11-07 10-Q 10-Q 0001723128-22-000039 001-38485 221365752 34 14148547 1 1
2022-11-04 8-K 8-K 2.02,7.01,9.01 0001723128-22-000037 001-38485 221360083 34 790940 1 1
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049156 5503
2022-09-08 3 FORM 3 SUBMISSION 0001209191-22-049149 6644
2022-09-06 8-K 8-K 5.02,7.01,9.01 0001193125-22-238857 001-38485 221228425 34 315144 1 1
2022-08-08 10-Q 10-Q 0001723128-22-000034 001-38485 221145039 34 13734783 1 1
2022-08-05 UPLOAD filename1.pdf 0000000000-22-008301 39608
2022-08-05 8-K 8-K 2.02,7.01,9.01 0001723128-22-000028 001-38485 221138485 34 790262 1 1
2022-08-04 CORRESP filename1.htm 0001193125-22-212429 25187
2022-08-03 8-K 8-K 5.02,7.01,9.01 0001193125-22-210639 001-38485 221131010 34 166229 1 1
2022-08-02 4 FORM 4 SUBMISSION 0001209191-22-044013 5535
2022-08-02 3 FORM 3 SUBMISSION 0001209191-22-044008 6585
2022-07-19 8-K 8-K 8.01 0001193125-22-196582 001-38485 221090318 34 147509 1 1
2022-07-05 4 FORM 4 SUBMISSION 0001209191-22-040624 9184
2022-06-27 UPLOAD filename1.pdf 0000000000-22-006877 43091
2022-06-02 8-K 8-K 1.01,1.02,2.03,9.01 0001723128-22-000023 001-38485 22992051 34 102404680 1 1
2022-05-13 8-K 8-K 5.07 0001723128-22-000019 001-38485 22923433 34 218377 1 1
2022-05-10 4 FORM 4 SUBMISSION 0001209191-22-028166 10524
2022-05-10 4 FORM 4 SUBMISSION 0001209191-22-028165 9402
2022-05-10 4 FORM 4 SUBMISSION 0001209191-22-028164 9188
2022-05-10 4 FORM 4 SUBMISSION 0001209191-22-028163 9217
2022-05-10 4 FORM 4 SUBMISSION 0001209191-22-028162 9457
2022-05-10 4 FORM 4 SUBMISSION 0001209191-22-028159 9382
2022-05-10 4 FORM 4 SUBMISSION 0001209191-22-028158 9581
2022-05-10 4 FORM 4 SUBMISSION 0001209191-22-028157 9417
2022-05-10 4 FORM 4 SUBMISSION 0001209191-22-028156 9456
2022-05-10 4 FORM 4 SUBMISSION 0001209191-22-028155 9389
2022-05-10 4 FORM 4 SUBMISSION 0001209191-22-028154 9201
2022-05-06 10-Q 10-Q 0001723128-22-000016 001-38485 22901875 34 10027115 1 1
2022-05-04 8-K 8-K 2.02,7.01,9.01 0001723128-22-000012 001-38485 22889704 34 706095 1 1
2022-03-25 DEFA14A AMNEAL PHARMACEUTICALS, INC. - DEF 14A 0001308179-22-000120 001-38485 22768278 34 793455
2022-03-25 DEF 14A AMNEAL PHARMACEUTICALS, INC. - DEF 14A 0001308179-22-000119 001-38485 22768271 34 2982307
2022-03-16 8-K 8-K 5.02 0001193125-22-077358 001-38485 22745819 34 139316 1 1
2022-03-15 4 FORM 4 SUBMISSION 0001209191-22-018891 7337
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-016056 20361
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-016055 20391
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-016054 6345
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-016051 6326
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-016050 12915
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-016049 8770
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-016047 20373
2022-03-02 S-3ASR S-3ASR 0001193125-22-062996 333-263226 22703713 33 634949
2022-03-02 S-3ASR S-3ASR 0001193125-22-062990 333-263225 22703683 33 248358
2022-03-02 8-K 8-K 2.02,7.01,9.01 0001723128-22-000008 001-38485 22701309 34 812140 1 1
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014150 9202
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014142 9232
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014133 9213
2022-03-01 10-K 10-K 0001723128-22-000006 001-38485 22698967 34 20709847 1 1
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-016475 005-90473 22606408 34 12968
2022-01-26 3 FORM 3 SUBMISSION 0000899243-22-003326 7707
2022-01-21 3 FORM 3 - AMNEAL PHARMACEUTICALS INC. 0001387131-22-000607 9779
2022-01-19 SC 13D/A AMENDED SC13D 0001387131-22-000440 005-90473 22536071 34 122445
2022-01-11 8-K 8-K 2.02,7.01 0001193125-22-006322 001-38485 22522778 34 151331 1 1
2022-01-05 8-K FORM 8-K 1.01,7.01,9.01 0001193125-22-002140 001-38485 22509372 34 755467 1 1
2021-12-20 4 FORM 4 SUBMISSION 0001209191-21-070646 6122
2021-12-17 4 FORM 4 SUBMISSION 0001209191-21-070259 7178
2021-12-17 4 FORM 4 SUBMISSION 0001209191-21-070258 7156
2021-12-17 4 FORM 4 SUBMISSION 0001209191-21-070257 4536
2021-12-03 4 FORM 4 SUBMISSION 0001209191-21-067956 4507
2021-11-08 10-Q 10-Q 0001723128-21-000039 001-38485 211388599 34 12379652 1 1
2021-11-03 8-K 8-K 2.02,7.01,9.01 0001723128-21-000035 001-38485 211373605 34 787544 1 1
2021-08-09 10-Q 10-Q 0001723128-21-000032 001-38485 211156421 34 11765827 1 1
2021-08-09 8-K 8-K 2.02,7.01,9.01 0001723128-21-000028 001-38485 211154511 34 751862 1 1
2021-07-01 4 FORM 4 SUBMISSION 0001209191-21-044367 9184
2021-05-11 4 FORM 4 SUBMISSION 0001209191-21-031567 12989
2021-05-11 4 FORM 4 SUBMISSION 0001209191-21-031566 13012
2021-05-11 4 FORM 4 SUBMISSION 0001209191-21-031565 13006
2021-05-10 8-K FORM 8-K 5.07 0001193125-21-156284 001-38485 21907571 34 166304 1 1
2021-05-07 10-Q 10-Q 0001723128-21-000023 001-38485 21902860 34 9497804 1 1
2021-05-07 4 FORM 4 SUBMISSION 0001209191-21-030815 9402
2021-05-07 4 FORM 4 SUBMISSION 0001209191-21-030814 9457
2021-05-07 4 FORM 4 SUBMISSION 0001209191-21-030813 10525
2021-05-07 4 FORM 4 SUBMISSION 0001209191-21-030812 9382
2021-05-07 4 FORM 4 SUBMISSION 0001209191-21-030811 9578
2021-05-07 4 FORM 4 SUBMISSION 0001209191-21-030809 9417
2021-05-07 4 FORM 4 SUBMISSION 0001209191-21-030807 9455
2021-05-07 4 FORM 4 SUBMISSION 0001209191-21-030806 9388
2021-05-07 8-K 8-K 2.02,7.01,9.01 0001723128-21-000020 001-38485 21900113 34 564502 1 1
2021-04-12 SC 13G/A SEC SCHEDULE 13G 0000902219-21-000351 005-90473 21819438 34 32825
2021-04-05 8-K FORM 8-K 7.01,9.01 0001193125-21-105627 001-38485 21803763 34 156169 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (468 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 348.41M 2026-10-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
dei EntityPublicFloat Entity Public Float USD 1.70B 2025-06-30 2025 FY 10-K 2026-02-27 0001723128-26-000011
ffd NetFeeAmt NetFeeAmt USD 69,506.15 2026-09-03 S-3ASR 2026-09-03 0001140361-26-035617
ffd TtlFeeAmt TtlFeeAmt USD 69,506.15 2026-09-03 S-3ASR 2026-09-03 0001140361-26-035617
ffd TtlOfferingAmt TtlOfferingAmt USD 503.30M 2026-09-03 S-3ASR 2026-09-03 0001140361-26-035617
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-03 S-3ASR 2026-09-03 0001140361-26-035617
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-09-03 S-3ASR 2026-09-03 0001140361-26-035617
ffd TtlTxValtn TtlTxValtn USD 1.33B 2026-06-18 PREM14A 2026-06-18 0001140361-26-025784
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 467.42M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001723128-23-000020
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 266.36M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001723128-25-000062
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 1.44B 2025-09-30 2025 Q3 10-Q 2025-11-06 0001723128-25-000062
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 545.76M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001723128-23-000020
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 19.42M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001723128-25-000062
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 27.49M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001723128-25-000062
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 633.39M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -83.08M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.05B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD 14.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 29.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 31.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 3.93M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001723128-25-000062
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 9.20M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001723128-22-000006
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 12.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 103.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 171,261 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001723128-18-000030
us-gaap AociLossCashFlowHedgeCumulativeGainLossAfterTax AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax USD 6.40M 2024-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap Assets Assets USD 5.27B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap AssetsCurrent Assets, Current USD 2.10B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD 22.52M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-03 0001723128-23-000009
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 2.09B 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-03 0001723128-23-000009
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 12.75M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001723128-26-000031
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD -6.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 383.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 59.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 324.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 2.23M 2021-11-02 2022 FY 10-K 2023-03-03 0001723128-23-000009
us-gaap CapitalLeasedAssetsNumberOfUnits Capital Leased Assets, Number of Units building 2 2018-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 39.00M 2018-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 266,000 2018-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 39.08M 2018-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 134.57M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 5.47M 2018-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFiveYears Capital Leases, Future Minimum Payments Due in Five Years USD 5.47M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 5.47M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 5.47M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 5.47M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap CapitalLeasesFutureMinimumPaymentsDueThereafter Capital Leases, Future Minimum Payments Due Thereafter USD 107.20M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments Capital Leases, Future Minimum Payments, Interest Included in Payments USD 95.22M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments USD 39.35M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear Capital Leases, Future Minimum Payments, Remainder of Fiscal Year USD 5.47M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 157.40M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001723128-18-000013
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 180.25M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -132.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap CashDivestedFromDeconsolidation Cash Divested from Deconsolidation USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001564590-20-024256
us-gaap CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months USD -19.20M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001723128-25-000047
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2020-03-31 2020 Q1 10-Q 2020-05-11 0001564590-20-024256
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2020-12-31 2021 Q1 10-Q 2021-05-07 0001723128-21-000023
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1,000 2018-03-31 2018 Q1 10-Q 2018-05-15 0001723128-18-000013
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 1,000 2018-03-31 2018 Q1 10-Q 2018-05-15 0001723128-18-000013
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 1,000 2018-03-31 2018 Q1 10-Q 2018-05-15 0001723128-18-000013
us-gaap CommonStockValue Common Stock, Value, Issued USD 10 2018-03-31 2018 Q1 10-Q 2018-05-15 0001723128-18-000013
us-gaap CommonUnitAuthorized Common Unit, Authorized shares 189.00M 2017-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap CommonUnitIssued Common Unit, Issued shares 189.00M 2017-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap CommonUnitOutstanding Common Unit, Outstanding shares 189.00M 2017-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 125.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 4.81M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 1.39B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 13.56M 2019-01-01 2019 Q2 10-Q 2019-08-05 0001723128-19-000111
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -1.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 11.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 11.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 1.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 3.05B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap DeferredCompensationArrangementWithIndividualContributionsByEmployer Deferred Compensation Arrangement with Individual, Contributions by Employer USD 0 2019-01-01 2019-01-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap DeferredCompensationLiabilityClassifiedNoncurrent Deferred Compensation Liability, Classified, Noncurrent USD 7.60M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 4.33M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001723128-22-000006
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 3.00M 2017-04-04 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 111.31M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001723128-22-000006
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 0 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.18M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 0 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory USD 60.00M 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 21.39M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 586.57M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 371.98M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 48.41M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 40.34M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 6.66M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 0 2024-12-31 2024 FY 10-K 2025-02-28 0001723128-25-000012
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 586.57M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 1.59M 2017-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 1.18M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2018-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 11.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap DepositsAssets Deposits Assets USD 3.75M 2024-12-31 2024 FY 10-K 2025-02-28 0001723128-25-000012
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 4.81M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap Depreciation Depreciation USD 40.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap DerivativeAssets Derivative Asset USD 33.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap DerivativeAssetsNoncurrent Derivative Asset, Noncurrent USD 33.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-03 0001723128-23-000009
us-gaap DistributionMadeToLimitedPartnerCashDistributionsDeclared Distribution Made to Limited Partner, Cash Distributions Declared USD 191.56M 2018-01-01 2018-05-03 2019 Q2 10-Q 2019-08-05 0001723128-19-000111
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2020-12-31 2020 FY 10-K 2021-03-01 0001723128-21-000013
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 30,000 2023-03-31 2023 Q1 10-Q 2023-05-09 0001723128-23-000020
us-gaap DueToAffiliateNoncurrent Due to Affiliate, Noncurrent USD 11.21M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001723128-23-000020
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 14.75M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001723128-23-000020
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 11.21M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001723128-23-000020
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.3 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -2.74 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.038 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.16 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD -4.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure -0.035 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.17 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001723128-25-000012
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 873,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure 0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure -0.048 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001723128-25-000012
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.029 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Amount USD -110.00M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001723128-22-000006
us-gaap EffectiveIncomeTaxRateReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent pure 0.082 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent pure -0.072 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001723128-25-000012
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -1.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 63.90M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001723128-25-000062
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 57.70M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap EscrowDeposit Escrow Deposit USD 24.20M 2025-12-31 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2020-03-31 2020 Q1 10-Q 2020-05-11 0001564590-20-024256
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2020-03-31 2020 Q1 10-Q 2020-05-11 0001564590-20-024256
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2020-03-31 2020 Q1 10-Q 2020-05-11 0001564590-20-024256
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2020-03-31 2020 Q1 10-Q 2020-05-11 0001564590-20-024256
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001564590-20-024256
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001564590-20-024256
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD -6.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases USD 389.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 383.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001723128-19-000111
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 4.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 4.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 58.37M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 3.81M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 65.59M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 99.83M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 68.25M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 7.58M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 5.64M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 5.79M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 6.11M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 6.45M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.37M 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041240
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 41.46M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 3.42M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 63.26M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 4.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.073 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 1.15B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired USD 56.40M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-07 0001723128-22-000039
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 73.37M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 162.95M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 45.03M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 92.59M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 105.99M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 104.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 117.47M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 1.85B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 702.15M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -12.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD -13.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap GainLossOnCashFlowHedgeIneffectivenessNet Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net USD 6.44M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-07 0001723128-25-000022
us-gaap GainLossOnContractTermination Gain (Loss) on Contract Termination USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001723128-19-000111
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD -2.81M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001723128-18-000037
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD -15.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -9.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap GainsLossesOnRestructuringOfDebt Gains (Losses) on Restructuring of Debt USD -291,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-07 0001723128-22-000039
us-gaap Goodwill Goodwill USD 772.47M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 179.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-03 0001723128-23-000009
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD -2.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001723128-25-000012
us-gaap GoodwillPurchaseAccountingAdjustments Goodwill, Purchase Accounting Adjustments USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001723128-24-000014
us-gaap GrantsReceivable Grants Receivable INR 10.00B 2021-11-30 2022 Q1 10-Q 2022-05-06 0001723128-22-000016
us-gaap GrossProfit Gross Profit USD 988.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 975,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001723128-23-000044
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001723128-24-000042
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 166.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD -4.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 11.88M 2020-12-31 2020 FY 10-K 2021-03-01 0001723128-21-000013
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 6.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD -110.00M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-03 0001723128-23-000009
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 5.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -22.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 29.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 762,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -119,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 1.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD -1.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 4.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap IncomeTaxReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount USD 11.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 17.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 122.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD -203,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD -34.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001723128-21-000032
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 158.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 5.82M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001723128-18-000030
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001723128-18-000013
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 4.33M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001723128-18-000030
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001723128-25-000012
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 113.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 1.65M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001723128-23-000031
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 849.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap InsuranceRecoveries Insurance Recoveries USD 1.91M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-14 0001723128-24-000014
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 2.70B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 1.55B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap InterestCostsCapitalized Interest Costs Capitalized USD 500,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001723128-18-000037
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -167.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 151.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap InterestRateCashFlowHedgeAssetAtFairValue Interest Rate Cash Flow Hedge Asset at Fair Value USD 33.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net USD -8.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap InterestRateCashFlowHedgeLiabilityAtFairValue Interest Rate Cash Flow Hedge Liability at Fair Value USD 11.47M 2021-12-31 2022 FY 10-K 2023-03-03 0001723128-23-000009
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 343.20M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap InventoryNet Inventory, Net USD 707.96M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 286.65M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 78.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap InventoryWriteDown Inventory Write-down USD 64.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap LeaseCost Lease, Cost USD 27.76M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap LegalFees Legal Fees USD 9.26M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041240
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 79.20M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 16.00M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 16.94M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 6.49M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 11.94M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 12.81M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 15.02M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 5.00M 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041240
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 20.40M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap Liabilities Liabilities USD 0 2018-03-31 2018 Q1 10-Q 2018-05-15 0001723128-18-000013
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 5.27B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 389.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.12B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 3.51B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest Limited Liability Company (LLC) Members' Equity, Including Portion Attributable to Noncontrolling Interest USD -375.58M 2017-12-31 2020 FY 10-K 2021-03-01 0001723128-21-000013
us-gaap LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity USD 245.90M 2023-06-30 2023 Q2 10-Q 2023-08-08 0001723128-23-000031
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 180.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap LitigationReserve Estimated Litigation Liability USD 79.30M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001723128-26-000020
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 27.53M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap LitigationReserveNoncurrent Estimated Litigation Liability, Noncurrent USD 71.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party USD 0 2022-07-01 2022-09-30 2023 Q3 10-Q 2023-11-09 0001723128-23-000044
us-gaap LitigationSettlementInterest Litigation Settlement Interest USD 700,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001723128-23-000031
us-gaap LongTermDebt Long-term Debt USD 2.94B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 2.68B 2018-09-30 2018 Q3 10-Q 2018-11-07 0001723128-18-000037
us-gaap LongTermDebtAndCapitalLeaseObligationsCurrent Long-term Debt and Lease Obligation, Current USD 44.23M 2020-12-31 2020 FY 10-K 2021-03-01 0001723128-21-000013
us-gaap LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities Long-term Debt and Lease Obligation, Including Current Maturities USD 2.80B 2018-09-30 2018 Q3 10-Q 2018-11-07 0001723128-18-000037
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 23.93M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 9.00M 2020-01-31 2020 Q2 10-Q 2020-08-06 0001723128-20-000013
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 27.00M 2018-05-04 2020 Q3 10-Q 2020-11-06 0001723128-20-000026
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 9.00M 2020-01-31 2020 Q2 10-Q 2020-08-06 0001723128-20-000013
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 27.00M 2018-05-04 2020 Q3 10-Q 2020-11-06 0001723128-20-000026
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 27.00M 2018-05-04 2020 Q3 10-Q 2020-11-06 0001723128-20-000026
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 27.00M 2018-05-04 2020 Q3 10-Q 2020-11-06 0001723128-20-000026
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 2.92B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap LossContingencyReceivable Loss Contingency, Receivable USD 0 2022-12-31 2022 FY 10-K 2023-03-03 0001723128-23-000009
us-gaap MediumtermNotesCurrent Medium-term Notes, Current USD 21.43M 2018-06-30 2018 Q2 10-Q 2018-08-09 0001723128-18-000030
us-gaap MembersCapital Members' Capital USD 2.72M 2017-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap MembersEquity Members' Equity USD -385.74M 2017-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap MembersEquityAttributableToNoncontrollingInterest Members' Equity Attributable to Noncontrolling Interest USD 10.16M 2017-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders USD 56.70M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap MinorityInterestDecreaseFromRedemptions Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests USD 3.48M 2018-05-04 2018-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 435.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -616.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 50.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 98.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 47.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 98.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 98.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest USD 112.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap NoncashMergerRelatedCosts Noncash Merger Related Costs USD 11.29M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 602,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001723128-24-000014
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001564590-20-024256
us-gaap NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1 Noncash or Part Noncash Divestiture, Amount of Consideration Received USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001564590-20-024256
us-gaap NoncontrollingInterestIncreaseFromBusinessCombination Noncontrolling Interest, Increase from Business Combination USD 2.00M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-07 0001723128-22-000039
us-gaap NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD 360,000 2018-01-01 2018-05-03 2019 Q2 10-Q 2019-08-05 0001723128-19-000111
us-gaap NoncurrentAssets Long-Lived Assets USD 550.33M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -200.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap NotesIssued1 Notes Issued USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 78.13M 2018-09-30 2018 Q3 10-Q 2018-11-07 0001723128-18-000037
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 40.13M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001723128-23-000020
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 3 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap NumberOfReportingUnits Number of Reporting Units Unit 2 2019-08-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap OperatingExpenses Operating Expenses USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001723128-18-000013
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 366.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-03 0001723128-23-000009
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 58.80M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap OperatingLeasePayments Operating Lease, Payments USD 17.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 54.05M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 97.56M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 25.89M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 10.04M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 10.33M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 11.11M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 12.07M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 28.13M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 6.05M 2018-09-30 2018 Q3 10-Q 2018-11-07 0001723128-18-000037
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 18.00M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.101 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 345.00M 2018-12-31 2022 FY 10-K 2023-03-03 0001723128-23-000009
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 60.28M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001723128-25-000062
us-gaap OtherAssetsMiscellaneousNoncurrent Other Assets, Miscellaneous, Noncurrent USD 20.70M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 122.81M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD -13.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax USD 18.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax USD 28.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxNoncontrollingInterest Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Noncontrolling Interest USD 27.00M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001723128-21-000013
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax USD 28.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax USD -8.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax USD 26.20M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -5.00M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001723128-24-000042
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax USD -3.41M 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-01 0001723128-22-000006
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001723128-22-000006
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 27.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherComprehensiveIncomeOtherNetOfTax Other Comprehensive Income, Other, Net of Tax USD 4.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherCostAndExpenseOperating Other Cost and Expense, Operating USD 5.40M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-06 0001723128-20-000026
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 41.46M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001723128-23-000020
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -4.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 1.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherNotesPayable Other Notes Payable USD 0 2024-09-30 2024 Q3 10-Q 2024-11-12 0001723128-24-000042
us-gaap OtherOperatingIncome Other Operating Income USD 1.20M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001723128-24-000014
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 8.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 34.12M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 9.44M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PartnersCapitalAccountContributions Partners' Capital Account, Contributions USD 27.74M 2018-01-01 2018-05-03 2019 Q2 10-Q 2019-08-05 0001723128-19-000111
us-gaap PartnersCapitalAccountReturnOfCapital Partners' Capital Account, Return of Capital USD 43,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap PartnersCapitalAccountUnitBasedCompensation Partners' Capital Account, Unit-based Payment Arrangement, Amount USD 158.76M 2018-01-01 2018-05-03 2019 Q2 10-Q 2019-08-05 0001723128-19-000111
us-gaap PaymentsForLegalSettlements Payments for Legal Settlements USD 42.00M 2022-07-01 2022-07-31 2022 Q3 10-Q 2022-11-07 0001723128-22-000039
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 5,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap PaymentsForRepurchaseOfRedeemableNoncontrollingInterest Payments for Repurchase of Redeemable Noncontrolling Interest USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001723128-25-000012
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 74.97M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-08 0001723128-21-000039
us-gaap PaymentsOfDividends Payments of Dividends USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001723128-21-000013
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 7.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 44.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PaymentsToAcquireAdditionalInterestInSubsidiaries Payments to Acquire Additional Interest in Subsidiaries USD 2.50M 2020-09-01 2020-09-30 2022 FY 10-K 2023-03-03 0001723128-23-000009
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 2.00M 2021-11-02 2021 FY 10-K 2022-03-01 0001723128-22-000006
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 421.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 96.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 70.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PaymentsToMinorityShareholders Payments to Noncontrolling Interests USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2018-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 196.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PrepaidExpenseAndOtherAssetsNoncurrent Prepaid Expense and Other Assets, Noncurrent USD 12.36M 2024-12-31 2024 FY 10-K 2025-02-28 0001723128-25-000012
us-gaap PrepaidInsurance Prepaid Insurance USD 6.79M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PrepaidTaxes Prepaid Taxes USD 14.48M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001723128-21-000013
us-gaap ProceedsFromDivestitureOfBusinessesNetOfCashDivested Proceeds from Divestiture of Businesses, Net of Cash Divested USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001723128-22-000006
us-gaap ProceedsFromIncomeTaxRefunds Proceeds from Income Tax Refunds USD 34.95M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap ProceedsFromInsuranceSettlementInvestingActivities Proceeds from Insurance Settlement, Investing Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001723128-25-000012
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 529.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap ProceedsFromIssuanceOfMediumTermNotes Proceeds from Issuance of Medium-term Notes USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-03 0001723128-23-000009
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 2.69B 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001723128-25-000062
us-gaap ProceedsFromLifeInsurancePolicies Proceeds from Life Insurance Policy USD 1.00M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-07 0001723128-22-000039
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 280.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041240
us-gaap ProceedsFromPaymentsToMinorityShareholders Proceeds from (Payments to) Noncontrolling Interests USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001723128-21-000013
us-gaap ProceedsFromRepaymentsOfLinesOfCredit Proceeds from (Repayments of) Lines of Credit USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001723128-21-000013
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets Proceeds from Sales of Business, Affiliate and Productive Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 516,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap ProductionRelatedImpairmentsOrCharges Production Related Impairments or Charges USD 5.11M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-08 0001723128-22-000034
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 159.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.21B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 572.63M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD -7,000 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001723128-18-000030
us-gaap ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock Receivable from Shareholders or Affiliates for Issuance of Capital Stock USD 10 2018-03-31 2018 Q1 10-Q 2018-05-15 0001723128-18-000013
us-gaap ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD -8.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap RedeemableNoncontrollingInterestEquityCarryingAmount Redeemable Noncontrolling Interest, Equity, Carrying Amount USD 12.56M 2020-03-31 2020 Q1 10-Q 2020-05-11 0001564590-20-024256
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-06 0001723128-22-000016
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001723128-19-000111
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 27.00M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap RepaymentsOfMediumTermNotes Repayments of Medium-term Notes USD 603.54M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001723128-18-000030
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount pure 0.9 2023-06-30 2023 Q2 10-Q 2023-08-08 0001723128-23-000031
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 145.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 7.07M 2018-06-30 2018 Q2 10-Q 2018-08-09 0001723128-18-000030
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 14.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 8.68M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 8.68M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD -44.30M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001723128-26-000020
us-gaap RestructuringCharges Restructuring Charges USD 2.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -436.78M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 2.38B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-08 0001723128-22-000034
us-gaap Revenues Revenues USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001723128-18-000013
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 1.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 23.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap RoyaltyExpense Royalty Expense USD 3.99M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001723128-24-000042
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 427.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 29.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001723128-22-000006
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 9.30M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.25M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 5.65 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 4.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 53,021 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 9.30M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.25M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 5.65 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.75 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 14.5 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001723128-22-000006
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 531.26M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 531.26M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap StockholdersEquityOther Stockholders' Equity, Other USD -4.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap StockIssued1 Stock Issued USD 491.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 712,069 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 491.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-01 0001723128-22-000006
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 0 2017-10-05 2017-12-31 2017 FY 10-K 2018-03-09 0001723128-18-000005
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD -44.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 516,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 13.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 1.07M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001723128-23-000020
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 14.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001723128-25-000012
us-gaap TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests USD 109.45M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap TemporaryEquityNetIncome Temporary Equity, Net Income USD 47.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap UndistributedEarningsOfForeignSubsidiaries Undistributed Earnings of Foreign Subsidiaries USD 142.50M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 4.03M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 1,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-03 0001723128-23-000009
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued Unrecognized Tax Benefits, Income Tax Penalties Accrued USD 0 2018-12-31 2018 FY 10-K 2019-03-01 0001723128-19-000028
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2017-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition Unrecognized Tax Benefits, Increase Resulting from Acquisition USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001723128-21-000013
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 251,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 74,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued Unrecognized Tax Benefits, Interest on Income Taxes Accrued USD 900,000 2024-12-31 2024 FY 10-K 2025-02-28 0001723128-25-000012
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense Unrecognized Tax Benefits, Interest on Income Taxes Expense USD 800,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001723128-25-000012
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 243,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 4.00M 2025-12-31 2025 FY 10-K 2026-02-27 0001723128-26-000011
us-gaap UnusualOrInfrequentItemInsuranceProceeds Unusual or Infrequent Item, or Both, Insurance Proceeds USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001723128-24-000014
us-gaap UnusualOrInfrequentItemLossGross Unusual or Infrequent Item, or Both, Loss, Gross USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001723128-24-000014
us-gaap UnusualOrInfrequentItemNetGainLoss Unusual or Infrequent Item, or Both, Net (Gain) Loss USD 5.37M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001723128-22-000006
us-gaap UnusualOrInfrequentItemNetOfInsuranceProceeds Unusual or Infrequent Item, or Both, Net of Insurance Proceeds USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001723128-24-000014
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 335.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 132.11M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008179
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 323.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001723128-26-000040

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →